6 Results
Epstein-Barr Virus’s Molecular Mimicry Reveals a Key Site of Vulnerability
NIAID scientists determined the high-resolution 3D structure of an Epstein-Barr virus (EBV) surface protein in complex with its receptor, revealing a key site of vulnerability that could lead to much-needed interventions against this common human pathogen.
Powerful Sequencing Tool Helps Identify Infectious Diseases in Mali
Advanced diagnostic tool tested in Mali helped identify infectious viruses in patients that normally would have required many traditional tests.
Vaccine Protective Against H5N1 Influenza from Cattle
Experimental H5N1 vaccine fully protective in mice against virus circulating in U.S. cattle.
NIAID Study Describes Successful Treatment Regimen for Person with Multidrug-Resistant HIV
A NIAID study describes the successful treatment of a person with multidrug-resistant (MDR) HIV with a regimen including the monoclonal antibody UB-421 (semzuvolemab) and lenacapavir-based ART.
Subclinical Disease in Monkeys Exposed to H5N1 by Mouth and Stomach
Drinking raw milk contaminated with H5N1 virus can cause infection but may be less severe. Regardless, exposure by raw milk should be avoided.
Measuring Innovation: Laboratory Infrastructure to Deliver Essential HIV Clinical Trial Results
HIV clinical trials network laboratory functions will continue to evolve to align with scientific priorities and research approaches.
